THRD — Third Harmonic Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $233.21m
- -$51.85m
- 34
- 38
- 26
- 24
Annual cashflow statement for Third Harmonic Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.8 | -29.6 | -35.2 | -30.8 | -45.5 |
| Depreciation | |||||
| Non-Cash Items | 1.88 | 11.1 | 3.73 | 10.4 | 11.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.74 | 2.74 | -3.49 | -0.013 | -0.522 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -9.19 | -15.7 | -34.9 | -20.4 | -34.5 |
| Capital Expenditures | — | — | -0.036 | -0.169 | -0.01 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.036 | -0.169 | -0.01 |
| Financing Cash Flow Items | — | — | -2.29 | -0.465 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 10.8 | 136 | 196 | 0.799 | 50.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.64 | 120 | 161 | -19.8 | 16 |